Flight Attendant Medical Research Institute Eleventh Scientific Symposium

Total Page:16

File Type:pdf, Size:1020Kb

Load more

FLIGHT ATTENDANT
MEDICAL RESEARCH
INSTITUTE
PUBLICATIONS AND
PRESENTATIONS
2002-2013

Table of Contents

Table of Contents................................................................................................................ 2 2013..................................................................................................................................... 4
Publications 2013............................................................................................................ 4 Presentations and Abstracts 2013 ................................................................................... 8 Book Chapters, etc., 2013............................................................................................. 11
2012................................................................................................................................... 12
Publications 2012.......................................................................................................... 12 Presentations and Abstracts 2012 ................................................................................. 34 Book Chapters, etc., 2012............................................................................................. 45
2011................................................................................................................................... 46
Publications 2011.......................................................................................................... 46 Presentations and Abstracts 2011 ................................................................................. 80 Book Chapters, etc., 2011............................................................................................. 93
2010................................................................................................................................... 94
Publications 2010.......................................................................................................... 94 Presentations and Abstracts 2010 ............................................................................... 128 Book Chapters, etc., 2010........................................................................................... 154
2009................................................................................................................................. 156
Publications 2009........................................................................................................ 156 Presentations and Abstracts 2009 ............................................................................... 192 Book Chapters, etc., 2009........................................................................................... 211
2008................................................................................................................................. 213
Publications 2008........................................................................................................ 213 Presentations and Abstracts 2008 ............................................................................... 241 Book Chapters, etc., 2008........................................................................................... 252
2007................................................................................................................................. 254
Publications 2007........................................................................................................ 254 Presentations and Abstracts 2007 ............................................................................... 272 Book Chapters, etc., 2007........................................................................................... 280
2006................................................................................................................................. 281
Publications 2006........................................................................................................ 281 Presentations and Abstracts 2006 ............................................................................... 296 Book Chapters, etc., 2006........................................................................................... 302
2005................................................................................................................................. 303
Publications 2005........................................................................................................ 303 Presentations and Abstracts 2005 ............................................................................... 317 Book Chapters, etc., 2005........................................................................................... 322
2004................................................................................................................................. 323
Publications 2004........................................................................................................ 323 Presentations and Abstracts 2004 ............................................................................... 331 Book Chapters, etc., 2004........................................................................................... 333
2003................................................................................................................................. 335
Publications 2003........................................................................................................ 335 Presentations and Abstracts 2003 ............................................................................... 339

2

Book Chapters, etc., 2003........................................................................................... 341
2002................................................................................................................................. 342
Publications 2002........................................................................................................ 342 Presentations and Abstracts 2002 ............................................................................... 343 Book Chapters, etc., 2002........................................................................................... 344

3

FAMRI Publications 2013

2013

Publications 2013

Apelberg BJ, Hepp LM, Avila-Tang E, Gundel L, Hammond SK, , Hovell MF, Hyland A, Klepeis NE, Madsen C, Navas-Acien A, Repace J, Samet JM, Breysse P. Environmental monitoring of secondhand tobacco smoke exposure. Tob Control 2013;22(3):147-155.

Avila-Tang E, Al-Delaimy W, Ashley DL, Benowitz NL, Bernert JT, Kim S, Samet JM, Hecht SS. Assessing secondhand smoke exposure using biological markers. Tob Control 2013 May;(3):164-171.

Avila-Tang E, Elf JL, Cummings KM, Fong GT, Hovell MF, Klein JD, McMillen R, Winickoff JP, Samet JM. Assessing secondhand smoke exposure with reported measures.

Tob Control 2013;22(3):156-163.

Baños-Lara Mdel R, Ghosh A, Guerrero-Plata A. Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J Virol 2013; 87(2):1242-1251.

Benowitz NL, Dempsey D, Tyndale RF, St Helen G, Jacob P 3rd. Dose-independent kinetics with low level exposure to nicotine and cotinine. Br J Clin Pharmacol 2013;75(1):277-279.

Brait M, Munari E, Lebron C, Noordhuis MG, Begum S, Michailidi C, Gonzalez-Roibon N, Maldonado L, Sen T, Guerrero-Preston R, Cope L, Parrella P, Fazio VM, Ha PK, Netto GJ, Sidransky D, Hoque MO. Genome-wide methylation profiling and the PI3K- AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle 2013;12(7).

Carson JL, Brighton LE, Collier AM, Bromberg PA. Correlative ultrastructural investigations of airway epithelium following experimental exposure to defined air pollutants and lifestyle exposure to tobacco smoke. Inhal Toxicol 2013;25(3):134-140.

Crane-Godreau MA, Payne P. A history of secondhand smoke exposure: are we asking the right questions? Front Physiol 2013;4:25.

D'Armiento JM, Goldklang MP, Hardigan AA, Geraghty P, Roth MD, Connett JE, Wise RA, Sciurba FC, Scharf SM, Thankachen J, Islam M, Ghio AJ, Foronjy RF. Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema. PLoS One 2013;8(2):e56352.

Deng X, Weerapana E, Ulanovskaya O, Sun F, Liang H, Ji Q, Ye Y, Fu Y, Zhou L, Li J, Zhang H, Wang C, Alvarez S, Hicks LM, Lan L, Wu M, Cravatt BF, He C. Proteomewide quantification and characterization of oxidation-sensitive cysteines in pathogenic bacteria. Cell Host Microbe 2013;13(3):358-370.

DiFranza J, Wellman R, Savageau JA, Beccia A, Ursprung WWSA, McMillen R. What

aspect of dependence does the Fagerström Test for Nicotine Dependence Measure? ISRN

Addiction 2013;2013:Article ID 906276, 8 pages Available at

http://www.hindawi.com/isrn/addiction/2013/906276/.

4

FAMRI Publications 2013

Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, Amariglio N, Rechavi G. Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc 2013;8(1):176-189.

Eppert BL, Wortham BW, Flury JL, Borchers MT. Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease. J Immunol 2013;190(3):1331-1340.

Gally F, Chu HW, Bowler RP. Cigarette smoke decreases airway epithelial FABP5

expression and promotes Pseudomonas aeruginosa infection. PLoS One

2013;8(1):e51784. García-Esquinas E, Loeffler LF, Weaver VM, Fadrowski JJ, Navas-Acien A. Kidney function and tobacco smoke exposure in US adolescents. Pediatrics [Epub 2013 Apr 8].

Geraghty P, Hardigan AA, Wallace AM, Mirochnitchenko O, Thankachen J, Arellanos L, Thompson V, D'Armiento JM, Foronjy RF. The GPx1-PTP1B-PP2A axis: a key determinant of airway inflammation and alveolar destruction. Am J Respir Cell Mol Biol [Epub 2013 Apr 5].

Goldklang MP, Marks SM, D’Armiento JM. Second hand smoke and COPD: lessons from animal studies. Front Physiol 2013;4:30.

Goldstein I, Rivlin N, Shoshana OY, Ezra O, Madar S, Goldfinger N, Rotter V. Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53. Carcinogenesis 2013;34(1):190-198.

Guan Y, Torres RM, Hartney JM. The influence of Arhgef1 on pulmonary leukocyte function. Immunol Res 2013;55(1-3):162-166.

Henschke CI, Yip R, Yankelevitz DF, Smith JP; International Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013;158(4):246-252.

Izhar L, Ziv O, Cohen IS, Geacintov NE, Livneh Z. Genomic assay reveals tolerance of DNA damage by both translesion DNA synthesis and homology-dependent repair in mammalian cells. Proc Natl Acad Sci U S A. 2013;110(16):E1462-1469.

Jabaut J, Ather JL, Taracanova A, Poynter ME, Ckless K. Mitochondrial dysfunction enhances IL-1β secretion independent of Nlrp3 S-glutathionylation. In press, Free

Radical Biology and Medicine 2013[Epub Jan 21].

Jones IA, St Helen G, Meyers MJ, Dempsey DA, Havel C, Jacob P 3rd, Northcross A, Hammond SK, Benowitz NL. Biomarkers of secondhand smoke exposure in automobiles. Tob Control 2013;01-07.

Jordaan G, Liao W, Sharma S. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors. BMC Cancer 2013;13(1):88.

Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D. Caspase-8 blocks kinase RIPK3- mediated activation of the NLRP3 inflammasome. Immunity 2013;38(1):27-40.

5

FAMRI Publications 2013

Kenche H, Baty CJ, Vedagiri K, Shapiro SD, Blumental-Perry A. Cigarette smoking affects oxidative protein folding in endoplasmic reticulum by modifying protein disulfide isomerase. FASEB J 2013;27(3):965-977.

Kim BS, Serebreni L, Hamdan O, Wang L, Parniani A, Sussan T, Stephens RS, Boyer L, Damarla M, Hassoun PM, Damico RL. Xanthine oxidoreductase is a critical mediator of cigarette smoke-induced endothelial cell DNA damage and apoptosis. Free Radic Biol Med [Epub 2013 Feb. 4].

Kratzer A, Salys J, Nold-Petry C, Cool C, Zamora M, Bowler R, Koczulla AR, Janciauskiene S, Edwards M, Dinarello CA, Taraseviciene-Stewart L. Role of IL-18 in second hand smoke-induced emphysema. Am J Respir Cell Mol Biol [Epub 2013 Feb 7].

Kulkarni R, Randis TM, Antala S, Wang A, Amaral FA, Ratner AJ βH/C of group B streptococci enhances host inflammation but is dispensable for establishment of urinary tract infection. PLoS One 2013; 8(3): e59091.

Laden F, Chiu YH, Garshick E, Hammond SK, Hart JE. A cross-sectional study of secondhand smoke exposure and respiratory symptoms in non-current smokers in the U.S. trucking industry: SHS exposure and respiratory symptoms. BMC Public Health. 2013;13(1):93.

Levy DE, Rigotti NA, Winickoff JP. Tobacco smoke exposure in a sample of Boston public housing residents. Am J Prev Med 2013;44(1):63-66.

Li H, Wood J, Whitten K, Vadival S, Seng S, Makriyannis A, Avraham S, Avraham H. Inhibition of fatty acid amide hydrolase activates Nrf2 signaling and induces heme oxygenase 1 transcription in breast cancer cells. Br J Pharmacol [Epub 2013 Jan].

Licht AS, Hyland A, Travers MJ, Chapman, S. Secondhand smoke exposure levels in outdoor hospitality venues: a qualitative and quantitative review of the research literature.

Tob Control 2013;22(3):172-179.

Liu Y, Antwi-Boampong S, Belbruno JJ, Crane-Godreau M, Tanski S. Detection of secondhand cigarette smoke via nicotine using conductive polymer films. Nicotine Tob Res [Epub 2013 Mar 11].

Madar S, Harel E, Goldstein I, Stein Y, Kogan-Sakin I, Kamer I, Solomon H, Dekel E, Tal P, Goldfinger N, Friedlander G, Rotter V. Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta. PLoS One 2013;8(4):e61353.

Mannam P, Zhang X, Shan P, Zhang Y, Shinn AS, Zhang Y, Lee PJ. Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury. J Immunol 2013;190(3):1264-1275.

Martin RA, Ather JL, Lundblad LKA, Suratt, BT, Boyson JE, Budd RC, Alcorn JF, Flavell RA, Eisenbarth SC., Poynter ME. Interleukin-1 receptor and caspase-1 are required for the Th17 response in NO2-promoted allergic airway disease. Am J Resp Cell & Mol Biol 2013 [Epub Jan 7].

Messier EM, Day BJ, Bahmed K, Kleeberger SR, Tuder RM, Bowler RP, Chu HW, Mason RJ, Kosmider B. NAC protects murine alveolar type II cells from cigarette smoke injury in an Nrf2-independent manner. Am J Respir Cell Mol Biol [Epub 2013 Mar 14].

6

FAMRI Publications 2013

Molchadsky A, Ezra O, Amendola PG, Krantz D, Kogan-Sakin I, Buganim Y, Rivlin N, Goldfinger N, Folgiero V, Falcioni R, Sarig R, Rotter V. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell

Death Differ 2013;20(5):774-783.

Peters EB, Christoforou N, Leong KW, Truskey GA. Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro. Tissue Eng Part A 2013;19(5-6):697-706.

Solomon O, Oren S, Safran M, Deshet-Unger N, Akiva P, Jacob-Hirsch J, Cesarkas K, Kabesa R, Amariglio N, Unger R, Rechavi G, Eyal E. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR). RNA 2013;19(5):591-604.

Tumati V, Kumar S, Yu L, Chen B, Choy H and Saha D. Effect of PF-02341066 (Crizotinib) and radiation in non small cell lung cancer cells. Oncol Rep 2013;29(3):1094-1100.

Turino GM, Ma S, Lin YY, Cantor JO, Luisetti M. Matrix elastin: A promising

biomarker for COPD. Am J Respir Crit Care Med 2011;184:637-641.

Vigodner M, Shrivastava V, Gutstein LE, Schneider J, Nieves E, Goldstein M, Feliciano M, Callaway M. Localization and identification of sumoylated proteins in human sperm: excessive sumoylation is a marker of defective spermatozoa. Hum Reprod 2013;28(1):210-223.

Weingarten-Gabbay S, Khan D, Liberman N, Yoffe Y, Bialik S, Das S, Oren M, Kimchi A. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA. Oncogene [Epub 2013 Jan 14].

Wilson AA, Kwok LW, Porter EL, Payne JG, McElroy GS, Ohle SJ, Greenhill SG, Blahna MT, Yamamoto K, Jean JC, Mizgerd J, and Kotton DN. Lentiviral delivery of RNAi for in vivo lineage specific modulation of gene expression in mouse lung macrophages. Mol Ther [Epub 2013 Feb 12].

Wilson, KM, Pier JC, Wesgate SC, Cohen J, Blumkin AK. Secondhand tobacco smoke exposure and severity of influenza in hospitalized children. JPediatr 2013;162(1):16-21.

Winickoff J, McMillen R, Klein JD. The Joint Commission’s new tobacco-cessation measures. Letter in response to: The opportunity for tobacco-cessation when a patient is hospitalized – going beyond the measures. N Engl J Med 2012;366(25):2429.

Wu Q, Case SR, Minor MN, Jiang D, Martin RJ, Bowler RP, Wang J, Hartney JM, Karimpour-Fard A, Chu HW. A novel function of MUC18: Amplification of lung inflammation during bacterial infection. Am J Pathol 2013;182(3):819-827.

Yankelevitz DF, Henschke CI, Yip R, Boffetta P, Shemesh J, Cham MD, Narula J, Hecht HS. Secondhand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. JACC Cardiovasc Imaging [Epub 2013 March 8].

Ye M, Zhang H, Amabile G, Yang H, Staber PB, Zhang P, Levantini E, Alberich-Jordà M, Zhang J, Kawasaki A, Tenen DG. C/EBPa controls acquisition and maintenance of adult hematopoietic stem cell quiescence. Nat Cell Biol [Epub 2013 Mar 17].

7

FAMRI Presentations and Abstracts 2013

Presentations and Abstracts 2013

Aravamudan B, Thompson MA, Pabelick CM, Prakash YS. Signaling mechanisms involved in cigarette smoke-induced alterations in airway smooth muscle mitochondrial morphology and dynamics. Presented at the American Thoracic Society International Conference. Philadelphia, PA, May 17-22, 2013.

Bhandary YP, Shetty SK, Marudamuthu AS, Ji H, Fu J, Idell S, Boggaram, VB, Neuenschwander PF, Morris GB and Shetty S. Regulation of alveolar epithelial injury and lung remodeling by p53-mediated changes in urokinase and plasminogen activator inhibitor-1 [abstract]. American Thoracic Society International Conference International Conference. Philadelphia, PA, May 17-22, 2013.

Brown KC, Lau JK, Thornhill BA, Crabtree CM, Dom AM, Witte TR, Hardman WE, McNees CA, Stover CM, Carpenter AB, Luo H, Chen YC, Shiflett BA, Dasgupta P. Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma. Presented at the Experimental Biology Conference. Boston, MA, Apr. 20, 2013.

Dasgupta P, Lau JK, Brown KC, Luo H, Chen YC. Nicotine increases the expression of alpha7-nicotinic receptors (alpha7-nAChRs) in human squamous cell lung cancer cells via Sp1/GATA pathway. Presented at the Experimental Biology Conference. Boston, MA Apr 20, 2013.

Degar,A; Kenche,H; Pandit,K.; Kaminski,N; Richards,D; Nelson,C and BlumentalPerry,A. miRNA-805 up-regulation in response to cigarette smoke challenge regulates alveolar type ii cells regeneration and repair capacity. Presented at the American Thoracic Society meeting. Philadelphia, PA, May 17-22, 2013. for COPD.

DiFranza JR, McMillen R, Wellman RJ. Black and Hispanic smokers are less likely than whites to be tobacco dependent. Presented at the Society for Research on Nicotine and Tobacco 19th Annual International Meeting, Boston MA, Mar 13-16, 2013.

Drehmer JE, Nabi-Burza E, Ossip D, Rigotti NA, Woo H, Chang Y, Winickoff JP. How thirdhand smoke beliefs of parents are associated with smoking attitudes and behaviors. Presented at the 2013 Pediatric Academic Societies Annual Meeting. Washington DC, May 4-7, 2013.

Groner J, Huang H, Eastman N, Lewis LM, Kuck J, Schanbacher BL, Hoffman R, Bauer JA. Oxidative stress in youth and adolescents exposed to secondhand smoke. Presented at the 2013 Pediatric Academic Societies Annual Meeting. Washington, DC, May 4-7, 2013.

Kim BS, Serebreni L, Hamdan O, Boyer L, P.M. Hassoun PM, Damico RL. Xanthine oxidoreductase is a critical mediator of cigarette smoke-induced endothelial cell DNA damage. Presented at the American Thoracic Society International Conference, Philadelphia, PA, May 17-22, 2013.

Levantini E,* Basseres DS, Zhang WC, Welner RS, Alberich-Jorda M, Yong KJ, Thakkar BM, Zhang J, Battelli C, Hetherington CJ, Ye M, O’Brien K, Magli MC, Loh M, Nga ME, Pang YH, Borczuk AC, Varticovski L, Kocher O, Zhang P, Soo RA, Lim B,

8

FAMRI Presentations and Abstracts 2013

Halmos B, Tenen DG*. C/EBPα acts as tumor suppressor in lung cancer by inhibiting the proto-oncogene Bmi-1. Presented at the Proceedings of the American Association for Cancer Research Annual Meeting, Washington, DC, Apr. 6-10, 2013.

Lopez J, Chupp GL, Gomez JL. Meta-analysis of the published asthma transcriptome identifies a protocadherin-gamma cluster. Presented at the American Thoracic Society Meeting, Philadelphia, PA, May 17-22, 2013.

Lu J, Zhang Y, Nguyen P, Fedulov A, Cernadas M, Kobzik L, Haley KJ. Maternal smoking causes postnatal T regulatory cell abnormalities. Presented at the American Thoracic Society Meeting, Philadelphia, PA, May 17-22, 2013.

Mahabee-Gittens E, Collins BN, Murphy SA, Woo H, Chang Y, Dempsey J, Weiley V, Winickoff JP. The parent-child dyad and parents who quit smoking successfully. Presented at the Pediatric Academic Societies Annual Meeting. Washington DC, May 4- 7, 2013.

McClelland E, Colvin L, Valentine N, McMillen R. Trends in poly-tobacco use among Mississippi secondary students. Presented at the 59th Annual Meeting of the Southeastern Psychological Association. Atlanta, GA, Mar 13-16, 2013.

Nabi-Burza E, Wasserman R, Chang Y, Finch S, Ossip D, Woo H, Winickoff JP. Do parents who smoke quit spontaneously? Presented at the Pediatric Academic Societies Annual Meeting. Washington, DC, May 4-7, 2013.

Ossip DJ, Woo H, Chang Y, Nabi-Burza E, Rigotti N, Winickoff JP. Do parents who smoke want their child’s pediatrician to address their smoking – and does it occur? Presented at the SRNT 19th Annual International Meeting. Boston MA, Mar 13-16, 2013.

Sathish V, Thompson MA, Freeman M, Jerde C, Pabelick CM, Prakash YS. Cigarette smoke exposure interferes with estrogen-induced NO production in human bronchial epithelial cells. Presented at the American Thoracic Society International Conference. Philadelphia, PA, May 17-22, 2013.

Recommended publications
  • Download Our Tobacco-Free Resource Guide for Youth

    Download Our Tobacco-Free Resource Guide for Youth

    educate. engage. empower. TOBACCO-FREE COMMUNITY FORUM TOBACCO-FREE RESOURCE GUIDE for Youth, Communities, Parents, and Schools TOBACCO-FREE COMMUNITY FORUM Educate. Engage. Empower. April 28, 2021 This event made possible by the Poe Center for Health Education in partnership with Wake County Human Services, Wake County Public Schools, and the American Heart Association . TOBACCO-FREE COMMUNITY FORUM AGENDA 9:15 a.m. - 9:30 a.m. - Log-In and Sign-On Slideshow of PhotoVoice Projects 9:30 a.m. - 9:40 a.m. - Welcome & Opening Remarks Honorable Sig Hutchinson, Wake County Commissioner Ann Rollins, Executive Director, Poe Center For Health Education Roxie Cash, Wake County Board of Education 9:40 a.m. - 9:45 a.m. - Recognition of Local Champions Presented by Youth Empowerment Team 9:45 a.m. - 10:00 a.m. - A Snapshot of Tobacco’s Impact on Youth In Wake County Sumedh Kotrannavar, Student at Carnage Middle School Teja Wasudev, Student at Cary Academy Nikhil Patel, Student at Enloe High School Gorja Yadav, Student at Enloe High School Lily Zahn, Student at Fuquay-Varina High School 10:00 a.m. - 10:20 a.m. - Latest Updates on Tobacco Impacts, Trends, and Statistics Jim Martin, Director of Policy and Programs with the N.C. Tobacco Prevention and Control Branch Division of Public Health, NC Department of Health and Human Services 10:20 a.m. - 10:45 a.m. - Youth Perspective on Local Tobacco Policy Needs Panel Moderator: Honorable Sig Hutchinson, Wake County Commissioner Panelists: Sumedh Kotrannavar, Student at Carnage Middle School Teja Wasudev, Student at Cary Academy Nikhil Patel, Student at Enloe High School Lily Zahn, Student at Fuquay-Varina High School 10:45 a.m.
  • (NON-FILTER) KS FSC Cigarettes: Premiu

    (NON-FILTER) KS FSC Cigarettes: Premiu

    PELICAN STATE WHOLESALE: PRODUCT LIST Code Product Category 91001 91001 AM SPRIT CIGS TAN (NON‐FILTER) KS FSC Cigarettes: Premium 91011 91011 AM SPRIT CIGS LIME GRN MEN MELLOW FSC Cigarettes: Premium 91010 91010 AM SPRIT CIGS BLACK (PERIQUE)BX KS FSC Cigarettes: Premium 91007 91007 AM SPRIT CIGS GRN MENTHOL F BDY BX KS Cigarettes: Premium 91013 91013 AM SPRIT CIGS US GRWN BRWN MELLOW BXKS Cigarettes: Premium 91009 91009 AM SPRIT CIGS GOLD MELLOW ORGANIC B KS Cigarettes: Premium 91002 91002 AM SPRIT CIGS LT BLUE FL BODY TOB BX K Cigarettes: Premium 91012 91012 AM SPRIT CIGS US GROWN (DK BLUE) BX KS Cigarettes: Premium 91004 91004 AM SPRIT CIGS CELEDON GR MEDIUM BX KS Cigarettes: Premium 91003 91003 AM SPRIT CIGS YELLOW (LT) BX KS FSC Cigarettes: Premium 91005 91005 AM SPRIT CIGS ORANGE (UL) BX KS FSC Cigarettes: Premium 91008 91008 AM SPRIT CIGS TURQ US ORGNC TOB BX KS Cigarettes: Premium 92420 92420 B & H PREMIUM (GOLD) 100 Cigarettes: Premium 92422 92422 B & H PREMIUM (GOLD) BOX 100 Cigarettes: Premium 92450 92450 B & H DELUXE (UL) GOLD BX 100 Cigarettes: Premium 92455 92455 B & H DELUXE (UL) MENTH BX 100 Cigarettes: Premium 92440 92440 B & H LUXURY GOLD (LT) 100 Cigarettes: Premium 92445 92445 B & H MENTHOL LUXURY (LT) 100 Cigarettes: Premium 92425 92425 B & H PREMIUM MENTHOL 100 Cigarettes: Premium 92426 92426 B & H PREMIUM MENTHOL BOX 100 Cigarettes: Premium 92465 92465 CAMEL BOX 99 FSC Cigarettes: Premium 91041 91041 CAMEL BOX KS FSC Cigarettes: Premium 91040 91040 CAMEL FILTER KS FSC Cigarettes: Premium 92469 92469 CAMEL BLUE BOX
  • Policy Statement—Tobacco Use: a Pediatric Disease Abstract

    Policy Statement—Tobacco Use: a Pediatric Disease Abstract

    Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of all Children Policy Statement—Tobacco Use: A Pediatric Disease COMMITTEE ON ENVIRONMENTAL HEALTH, COMMITTEE ON abstract SUBSTANCE ABUSE, COMMITTEE ON ADOLESCENCE, AND COMMITTEE ON NATIVE AMERICAN CHILD HEALTH Tobacco use and secondhand tobacco-smoke (SHS) exposure are ma- jor national and international health concerns. Pediatricians and other KEY WORDS tobacco, smoke, cigarette, environmental tobacco, nicotine, clinicians who care for children are uniquely positioned to assist pa- secondhand, smoke free, cigar, smokeless tients and families with tobacco-use prevention and treatment. Under- ABBREVIATIONS standing the nature and extent of tobacco use and SHS exposure is an SHS—secondhand tobacco smoke essential first step toward the goal of eliminating tobacco use and its AAP—American Academy of Pediatrics DoD—Department of Defense consequences in the pediatric population. The next steps include coun- This document is copyrighted and is property of the American seling patients and family members to avoid SHS exposures or cease Academy of Pediatrics and its Board of Directors. All authors tobacco use; advocacy for policies that protect children from SHS ex- have filed conflict of interest statements with the American posure; and elimination of tobacco use in the media, public places, and Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American homes. Three overarching principles of this policy can be identified: (1) Academy of Pediatrics has neither solicited nor accepted any there is no safe way to use tobacco; (2) there is no safe level or dura- commercial involvement in the development of the content of tion of exposure to SHS; and (3) the financial and political power of this publication.
  • Download Full Curriculum Vitae

    Download Full Curriculum Vitae

    Pollay CV (Feb 2013)...1 of 45 Sauder School of Business THE UNIVERSITY OF BRITISH COLUMBIA 2053 Main Mall, Vancouver, BC, Canada V6T 1Z2 CURRICULUM VITAE (as of February 2013) RICHARD W. POLLAY Home Address Professor Emeritus, Marketing Division 4506 West 8th Avenue Curator, History of Advertising Archives Vancouver, BC V6R 2A5 (604) 224-7322 Office Phone: (604) 822-8338 e-mail: [email protected] I. BIOGRAPHICAL DATA Place of Birth: New Britain, CT (USA) Sex: Male Date of Birth: June 28, 1940 Marital Status: Married Citizenship: Canadian & US Children: None II. EDUCATION a) Undergraduate 1958-1962: Rensselaer Polytechnic Institute, B. Management Engineering b) Graduate 1962-1963: University of Chicago, Masters of Business Administration 1964-1966: University of Chicago, Ph.D. (awarded, 1970) c) Graduate Theses Titles Ph.D.: "A Theoretical and Experimental Investigation into the Factors Affecting Decision Completion Time" d) Academic Awards Prior to Final Degree Ford Foundation Research Fellowship, Summer 1968 Sears and Roebuck Doctoral Fellowship, 1965 American Marketing Association, Certificate of Merit, 1962 Degree cum laude, Rensselaer Polytechnic Institute, 1962 Tau Beta Pi (Engineering Honorary) Epsilon Delta Sigma (Business Honorary) III. PROFESSIONAL EMPLOYMENT RECORD a) Teaching or Research Positions Held Prior to UBC Appointment 1966-1970: Assistant Professor, University of Kansas b) Date of First UBC Appointment: July 1, 1970 Pollay CV (Feb 2013)...2 of 45 c) Rank of First Appointment: Associate Professor d) Subsequent Ranks
  • Commercial Tobacco-Free K-12 School Model Policy: Questions & Answers 2 November 2019

    Commercial Tobacco-Free K-12 School Model Policy: Questions & Answers 2 November 2019

    TOBACCO-FREE November 2019 SCHOOLS COMMERCIAL TOBACCO-FREE K-12 SCHOOL MODEL POLICY Questions & Answers The use or promotion of commercial tobacco products1 on school grounds and at off‑campus school‑sponsored events is detrimental to the health and safety of students, staff, and visitors. Under federal law, smoking is prohibited in any kindergarten, elementary, or secondary school or library serving children under the age of 18 years if federal funds are used in the school.2 Many states also have laws that restrict commercial tobacco use, including electronic cigarettes, in public K–12 schools.3 However, federal law and many state laws do not cover outdoor school grounds. www.publichealthlawcenter.org November 2019 To promote an environment free of commercial tobacco in primary and secondary schools, the Public Health Law Center has prepared a comprehensive model policy that school districts and schools may adopt. The policy: { Provides a definition of commercial tobacco products to include current and future tobacco products; { Prohibits the following items on campus (inside and outside buildings) and at off-campus, school-sponsored events: ] Tobacco products and tobacco-related devices, including electronic cigarettes, ] Imitation tobacco products (such as candy cigarettes), and ] Lighters; { Prohibits accepting any donations or curriculum from any tobacco-related industry; { Prohibits any promotion of tobacco products, including electronic cigarette products; and { Includes effective and holistic enforcement options for student violations beyond suspension and expulsion. Both this publication and Commercial Tobacco-Free K–12 School Model Policy reflect this policy. In addition to the model policy language summarized above, this model policy Q & A document includes context boxes throughout the model policy that provide the reasoning behind key provisions.
  • November 7, 2007 Section: News

    November 7, 2007 Section: News

    November 7, 2007 Section: News SMOKELESS? Maybe, but powder from fake cigar sickens Healdton woman Steve Biehn HEALDTON Karen Morrision got an unpleasant surprise when she inhaled "smoke" from a novelty cigar a few weeks ago. Morrison said she became ill after she accidently sucked on the cigar. The fake cigars are filled with a light powder and are designed so when the user gently blows on one end, curls of "smoke" escape from the tip. Morrison said the powder made her nauseated and she experienced a tightness in her chest for about 24 hours afterwards. "It was a really fine, fine dust that I breathed in," she said. "It looked like smoke." Morrison wants to know if the effects of inhaling the powder might be lasting or could present a danger to children. The Daily Ardmoreite requested information about the cigars from the federal Consumer Product Safety Commission last week but has not yet received a response. Phoney cigars and cigarettes typically contain instructions on the packaging warning users to not inhale or ignite the product. Morrison admitted she was "goofing around" when she accidently inhaled the powder. However, she is concerned young children might make the same mistake. Puff Cigars and Puff Cigarettes are made in Tiawan and are available at toy and novelty stores and online. A friend's children purchased Morrision's cigar from a street vendor during Healdton's Oil Day celebration on Oct. 20. Anti-smoking advocates worry that candy cigarettes, shredded bubble gum and phoney cigars may encourage youngsters to take up smoking, chewing or dipping.
  • Refor T Resumes

    Refor T Resumes

    REFOR TRESUMES ED 016 102 VT 004 065 A PERSONAL ADJUSTMENT AND PRE-VOCATIONALCENTER FOR NON- FEASIBLE DEAF ADULTS AND RESEARCH TO DISCOVERAND ESTABLISH - -(1) THE EXTENT TO WHICH VOCATIONALREHABILITATION CAN BE ACHIEVED, (2) THE TIME REQUIRED, AND (3) THE COST. FINAL PROJECT REPORT. BY- RETHERFORD, ROBERT M. MICHIGAN ASSN. FOR BETTER HEARING, EAST LANSING PUB DATE 65 EDRS PRICE MF-$0.75 HC-$7.66 190P. DESCRIPTORS- *VOCATIONAL REHABILITATION, *DEAF, SOCIAL ADJUSTMENT, *PREVOCATIONAL EDUCATION, DEMONSTRATIONPROJLCTS, *PROGRAM DEVELOPMENT, MEDICAL EVALUATION,PSYCHOLOGICAL EVALUATION, ADMISSION CRITERIA, JOB PLACEMENT,PROGRAM COSTS, *ADJUSTMENT (TO ENVIRONMENT), ADULT BASIC EDUCATION, VOCATIONAL TRAINING CENTERS, VOCATIONAL ADJUSTMENT,TEST RESULTS, COMMUNICATION SKILLS, INDIVIDUALCHARACTERISTICS, DEAF MEN WHOSE HANDICAPS WERE BEYOND THE SCOPEOF AVAILABLE STATE SERVICES WERE ENROLLED IN A PROGRAM TO DEVELOP READINESS FOR VOCATIONAL REHABILITATION. THE 33 TRAINEES WERE GIVEN INSTRUCTION IN COMMUNICATION,READING, SOCIAL STUDIES, ARITHMETIC, SOCIAL ADJUSTMENT.OCCUPATIONAL TRAINING, DRIVER EDUCATION, AND PREEMPLOYMENTTRAINING. TRADITIONAL CLASSROOM TEACHING TECHNIQUES WERE USED. THE SMALL SIZE OF THE TRAINEE SAMPLE, THE INADEQUACYOF INFORMATION ABOUT THE DEAF CLIENTS, AND THE LACK OFRELEVANT NORMATIVE DATA SHOULD BE CONSIDERED IN CONNECTION WITH THE FOLLOWING FINDINGS--(1) THE MAJORITY OF TRAINEESOBTAINED SOME TYPE OF EMPLOYMENT,(2) EVIDENTLY MOST OF THE MEN REACHED A LEARNING PLATEAU IN THE SIXTH' AND EIGHTHMONTHS OF TRAINING,(3) ALTHOUGH ACADEMIC SKILL IMPROVED LITTLE,THERE WAS EVIDENCE THAT EXPOSURE TO FORMAL INSTRUCTIONBROADENED COMMUNICATION SKILLS AND MADE POSSIBLE MORE CONTACT WITH OTHER TRAINEES AS WELL AS WITH OTHER DEAFOUTSIDE, AND (4) THE 33 MEN SPENT AN AVERAGE OF 368.2 DAYSIN RAINING AT AN AVERAGE COST OF APPROXIMATELY $10,250 PER MAN PERYEAR.
  • Exposing and Addressing Tobacco Industry Conduct in Low-Income and Middle-Income Countries Anna B

    Exposing and Addressing Tobacco Industry Conduct in Low-Income and Middle-Income Countries Anna B

    Marquette University e-Publications@Marquette Political Science Faculty Research and Publications Political Science 3-14-2015 Exposing and Addressing Tobacco Industry Conduct in Low-Income and Middle-Income Countries Anna B. Gilmore University of Bath Gary Fooks University of Bath Jeffrey Drope Marquette University, [email protected] Stella Aguinaga Bialous University of California, San Francisco Rachel Rose Jackson University of Bath Accepted version. Lancet, Vol 385, No. 9972 (March 14, 2015): pg. 1029-1043. DOI. © 2015 Elsevier. Used with permission. NOTICE: this is the author’s version of a work that was accepted for publication in Lancet. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Lancet, Vol 385, No. 9972 (March 14, 2015): pg. 1029-1043. DOI. NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be accessed by following the link in the citation at the bottom of the page. Exposing and Addressing Tobacco Industry Conduct in Low-Income and Middle-Income Countries Anna B. Gilmore Department for Health and UK Centre for Tobacco and Alcohol Studies, University of Bath, Bath, UK Gary Fooks Department for Health and UK Centre for Tobacco and Alcohol Studies, University of Bath, Bath, UK Jeffrey Drope American Cancer Society, Atlanta, GA Department of Political Science, Marquette University, Milwaukee, WI Stella Aguinaga Bialous Social & Behavioral Sciences, School of Nursing, University of California, San Francisco, CA Lancet, Vol 385, No.
  • A Smoking Gun:

    A Smoking Gun:

    Why are tobacco companies allowed to spend $11/2 billion dollars per year to pro­ mote deadly products-with many of their messages intended for children? How can this situation be tolerated? How did it arise? What can we do about it? Can pro­ tection be achieved in a manner compati­ ble with free enterprise and individual freedom? How should the rights of smokers and nonsmokers be balanced? Must nonsmokers subsidize the cost of treating cigarette-induced disease? How much protection should nonsmokers have from drifting cigarette smoke? How can smokers escape from the grip of nicotine addiction and psychological dependence on smoking? Dr. Elizabeth Whelan addresses these and other important questions as she examines how the tobacco industry de­ veloped and thrived during the 20th century, creating an unprecedented chain of economic and physical dependence. She discusses the early launching of the Dr. Elizabeth M. Whelan is Executive Di­ cigarette, its initial rejection by those ac­ rector of the American Council on Science customed to the more "manly" pipe and and Health. She holds advanced degrees in cigar, and finally, its stellar success, result­ epidemiology and public health education ing in large part from an unparalleled from the Yale School of Medicine and the advertising blitz. Harvard School of Public Health, and has In many ways, the cigarette represents written extensively on a variety of topics just plain bad li.ick. By the time that the relating to the environment and public data on cigarette smoking and disease be­ health. Dr. Whelan resides in New York came conclusive in the 1950s, a substan­ City with her husband and daughter.
  • The Art and Design You Need to See During Art Basel Miami Beach

    The Art and Design You Need to See During Art Basel Miami Beach

    11,397 views | Dec 3, 2017, 05:28pm All The Art And Design You Need To See During Art Basel Miami Beach Rebecca Suhrawardi Contributor Showing at Art Basel Miami Beach, Sally Mann, Candy Cigarette © Sally Mann. Courtesy of Edwynn Houk Gallery, New York. EDWYNN HOUK GALLERY Starting today, people from all around the world will flock to the sunny shores of Miami Beach over the next week for Art Basel’s stateside fair. What started in Basel, Switzerland in the 70’s saw itself extend to Miami in 2002 and has grown to become the premier contemporary art fair in the Americas. Its massive popularity spurred the creation of another fair alongside it, Design Miami/, which focuses solely on design and has become the showcase for the best the world of contemporary design has to offer. With both fairs taking place next week, Miami overflows with things to do and see, and it attracts more than just galleries, collectors, artists and designers, but also brands and individuals have a strong presence in Miami during this time. See below for a guide showcasing the must-see art and design shows happening at Art Basel Miami Beach, so you don't miss a beat. Art Basel Miami Beach, 2016 ART-BASEL YOU MAY ALSO LIKE ART BASEL The raison d’être. Art Basel is the art fair at the center of the week’s events. Now in its 16th edition, Art Basel will welcome over 268 galleries from more than 32 countries who will convene on the floor the Miami Beach Convention Center, where the fair has been housed since 2002.
  • Illicit Tobacco in Australia

    Illicit Tobacco in Australia

    Illicit tobacco in Australia 2016 Full Year Report 20 March 2017 © 2017 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms 0 affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. KPMG LLP Tel +44 (0) 20 7311 1000 Strategy Group Fax +44 (0) 20 7311 3311 15 Canada Square DX 157460 Canary Wharf 5 Canary Wharf London E14 5GL United Kingdom 20 March 2017 Important notice This presentation of key findings (the ‘Report’) has been prepared by KPMG LLP in the UK (‘KPMG UK’) for Philip Morris Limited and Imperial Tobacco Australia Limited, described together in this Important Notice and in this Report as the ‘Beneficiaries’, on the basis set out in a private contract dated 16 September 2016 agreed separately with the Beneficiaries. Nothing in this Report constitutes legal advice. Information sources, the scope of our work, and scope and source limitations, are set out in the Appendices to this Report. The scope of our review of the contraband, counterfeit and unbranded segments of the tobacco market within Australia was fixed by agreement with the Beneficiaries and is set out in the Appendices. We have satisfied ourselves, so far as possible, that the information presented in this Report is consistent with our information sources but we have not sought to establish the reliability of the information sources by reference to other evidence. This Report has not been designed to benefit anyone except the Beneficiaries. In preparing this Report we have not taken into account the interests, needs or circumstances of anyone apart from the Beneficiaries, even though we have been aware that others might read this Report.
  • 1455189355674.Pdf

    1455189355674.Pdf

    THE STORYTeller’S THESAURUS FANTASY, HISTORY, AND HORROR JAMES M. WARD AND ANNE K. BROWN Cover by: Peter Bradley LEGAL PAGE: Every effort has been made not to make use of proprietary or copyrighted materi- al. Any mention of actual commercial products in this book does not constitute an endorsement. www.trolllord.com www.chenaultandgraypublishing.com Email:[email protected] Printed in U.S.A © 2013 Chenault & Gray Publishing, LLC. All Rights Reserved. Storyteller’s Thesaurus Trademark of Cheanult & Gray Publishing. All Rights Reserved. Chenault & Gray Publishing, Troll Lord Games logos are Trademark of Chenault & Gray Publishing. All Rights Reserved. TABLE OF CONTENTS THE STORYTeller’S THESAURUS 1 FANTASY, HISTORY, AND HORROR 1 JAMES M. WARD AND ANNE K. BROWN 1 INTRODUCTION 8 WHAT MAKES THIS BOOK DIFFERENT 8 THE STORYTeller’s RESPONSIBILITY: RESEARCH 9 WHAT THIS BOOK DOES NOT CONTAIN 9 A WHISPER OF ENCOURAGEMENT 10 CHAPTER 1: CHARACTER BUILDING 11 GENDER 11 AGE 11 PHYSICAL AttRIBUTES 11 SIZE AND BODY TYPE 11 FACIAL FEATURES 12 HAIR 13 SPECIES 13 PERSONALITY 14 PHOBIAS 15 OCCUPATIONS 17 ADVENTURERS 17 CIVILIANS 18 ORGANIZATIONS 21 CHAPTER 2: CLOTHING 22 STYLES OF DRESS 22 CLOTHING PIECES 22 CLOTHING CONSTRUCTION 24 CHAPTER 3: ARCHITECTURE AND PROPERTY 25 ARCHITECTURAL STYLES AND ELEMENTS 25 BUILDING MATERIALS 26 PROPERTY TYPES 26 SPECIALTY ANATOMY 29 CHAPTER 4: FURNISHINGS 30 CHAPTER 5: EQUIPMENT AND TOOLS 31 ADVENTurer’S GEAR 31 GENERAL EQUIPMENT AND TOOLS 31 2 THE STORYTeller’s Thesaurus KITCHEN EQUIPMENT 35 LINENS 36 MUSICAL INSTRUMENTS